HLB
42,350KRWMarket close of 10/21 (Wed)
Down -1.51%-650KRWMarket close of 10/21 (Wed)
- Open
- 42,900
- High
- 43,650
- Low
- 42,150
- Day range
- Day range low 42,150 high 43,650, open 42,900, close 42,350, previous close 43,000
- Volume
- 38×10K shares
- 16.3B KRW 0.23× the 20-session average
Market close of 10/21 (Wed)
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-98.1B KRWOperating income over the last four quarters -98.1B KRW (loss)
- Daily movenot verifiedOnly 15 daily bars to compare, so not verified
- Trading valuenot verifiedNot enough 20-session trading value data, so not verified
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional+16.1B KRWusual range
- Data date10/21 (Wed)Market close
See the full check report
Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 25 days
- Next data 10/23 (Fri) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.